Injections designed to protect against SARS-CoV-2 that contain polyethylene glycol (PEG) cause some people to develop PEG-specific antibodies, according to a peer-reviewed article “Anti-PEG Antibodies Boosted in Humans by SARS-CoV-2 Lipid Nanoparticle mRNA Vaccine” published in June 2022 on ACS Publications by a team of Australian scientists.
The first author of the article, along with experts from Ireland and the United States, have just followed up their research with a commentary published on December 20, 2022 in the journal Nature Reviews Immunology. Their commentary, “Impact of anti-PEG antibodies induced by SARS-CoV-2 mRNA vaccines,” reinforces the message that antibodies against PEG may be causing health problems. As the authors insist: “larger and longer studies are needed to analyze the longer-term impact of boosting anti-PEG antibodies by LNP mRNA vaccination.”
